Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PrioSense was an Israeli private biotechnology company focused on diagnostics and therapeutics for prion diseases affecting humans and animals. Available sources indicate it was founded as a Hadasit spin-off based on work from Hadassah University Medical Center and worked on prion-related products for diseases such as Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Registry-style business sources identify the company as PRIOSENSE LTD and indicate that it was voluntarily dissolved, with the last annual report filed in 2004. Publicly available current evidence does not show an active operating business, marketed products, or an ongoing clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PrioSense.